Science Study Finds Beating Heart Cuts Tumor Growth to 20% via Nesprin-2 Pathway
Updated
Updated · Medscape · Jun 23
Science Study Finds Beating Heart Cuts Tumor Growth to 20% via Nesprin-2 Pathway
1 articles · Updated · Medscape · Jun 23
Summary
Mouse experiments showed cancer cells barely expanded in the native beating heart but replaced nearly all tissue in an unloaded transplanted heart within 14 days.
Mechanical stress—not poorer engraftment, cell death, or metabolic competition—suppressed proliferation, and engineered cardiac tissues showed tumor growth falling as load increased.
Gene analyses linked that effect to chromatin remodeling and activation of cell-division suppressor genes; disabling Nesprin-2 let cancer cells resume growth despite mechanical load.
The findings may explain why primary heart tumors appear in under 1% of autopsies and point to early-stage ideas such as wearable mechanical stimulators or drugs that mimic the effect.
Could wearable devices that mimic the heart's rhythm become a new weapon in the fight against cancer?
Is the next cancer breakthrough not a drug, but harnessing the physical forces of our own bodies?
Why the Heart Rarely Gets Cancer: How Mechanical Forces Suppress Tumor Growth and What It Means for Future Cancer Therapies
Overview
Scientists have long wondered why the heart is so resistant to cancer, even though cancer cells travel through the bloodstream and pass through the heart regularly. Historically, this was thought to be due to the heart's limited ability to regenerate its cells, since cancer is often linked to uncontrolled cell growth. However, new research shows that the heart's constant mechanical activity—its continuous beating—creates an environment that makes it hard for cancer cells to grow. This discovery highlights how the heart's unique physical forces help protect it from cancer, offering new ideas for cancer prevention and treatment.